| Financial Year |
March 31 2023 |
| Monetary Funds |
120,809,704.86 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
452,575,140.52 |
| Accounts Receivable |
390,326,181.94 |
| Advances to Suppliers |
4,401,114.75 |
| Other Receivables |
2,461,702.58 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
89,976.85 |
| Dividend Receivable |
-- |
| Inventories |
124,734,441.21 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
41,551,010.91 |
| Total Current Assets |
1,228,908,590.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
208,363,133.30 |
| Investment Properties |
-- |
| Fixed Assetes |
212,484,615.61 |
| Under-construction Projects |
25,211,089.77 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,780,919.28 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
152,883.06 |
| Deferred Income Tax Assets |
5,783,790.31 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
490,773,363.68 |
| Total Assets |
1,719,681,954.60 |
| Short-Term Loans |
94,456,868.06 |
| Trading Financial liabilities |
71,153.96 |
| Notes Payable |
60,527,705.25 |
| Accounts Payable |
188,289,669.36 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
7,155,999.72 |
| Taxes Payable |
21,674,092.93 |
| Interest Payable |
7,655.04 |
| Dividend Payable |
-- |
| Other payables |
35,936,994.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,727,527.20 |
| Other Current Liabilities |
136,044,833.55 |
| Sub-Total of Current Liabilities |
553,819,570.32 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,221,951.63 |
| Total Liabilities |
557,041,521.95 |
| Paid-In Capital(Or Share Stock) |
403,200,000.00 |
| Capital Surplus |
324,442,470.00 |
| Surplus Reserve |
34,698,077.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
355,194,309.58 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,162,640,432.65 |
| Owner's Equity（Stockholder's Equity） |
1,162,640,432.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,719,681,954.60 |
